Is it ever worth compromising on quality in clinical research? My answer is a definite ‘no’. I’m not alone in this view, since building quality into everything we do is an everyday challenge. But, I wonder how in today’s economic climate, the pharmaceutical industry satisfies the demand for quicker, better-quality clinical evidence, for regulatory submission, … Continue reading